Illumina, Affymetrix, Genome Explorations, CombiMatrix, OGT, Invitrogen, Protagen | GenomeWeb
Illumina to Grow Sales Staff by at Least Half in '06; Affy Suit Could Go to Court in Early March
 
Illumina’s global sales staff will increase by at least half this year as the company sets to roll out its BeadXpress molecular diagnostic platform, a company official said this week.
 
CEO Jay Flatley, speaking to investors at the UBS Global Life Sciences Conference in New York, said Illumina’s sales staff will grow by between 50 percent and 60 percent this year over last.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.